Walpar Nutritions Limited (NSE:WALPAR)

India flag India · Delayed Price · Currency is INR
45.50
-2.35 (-4.91%)
At close: Jan 29, 2026
-4.31%
Market Cap 427.27M
Revenue (ttm) 757.46M
Net Income (ttm) 23.31M
Shares Out 9.39M
EPS (ttm) 2.49
PE Ratio 18.31
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,000
Average Volume 5,200
Open 45.50
Previous Close 47.85
Day's Range 45.50 - 45.50
52-Week Range 37.70 - 53.30
Beta -0.52
RSI 52.79
Earnings Date Feb 12, 2026

About Walpar Nutritions

Walpar Nutritions Limited manufactures and trades pharmaceutical, nutraceutical, herbal, and ayurvedic commodities in India. The company offers G-Flora, a probiotic blend for gut health and immunity; Inosia-F, an inositol supplement; Inovam Plus, a multivitamin; Ironica-CR, controlled-release iron supplement; Myobest, muscle support formula; Ovality, ovarian health support; Ovanyx-F, a female reproductive health supplement; Ovacon-F, women's fertility support; PCOS Care Forte, a PCOS support; Procive-F, female fertility enhancement supplement; ... [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Country India
Stock Exchange National Stock Exchange of India
Ticker Symbol WALPAR
Full Company Profile

Financial Performance

In fiscal year 2025, Walpar Nutritions's revenue was 719.60 million, an increase of 14.93% compared to the previous year's 626.13 million. Earnings were 23.24 million, an increase of 46.92%.

Financial Statements

News

There is no news available yet.